Position in EXEL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,146,527
+$241,077 QoQ
Shares Held
21,072
-0.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#327
of 756 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krilogy Financial LLC holds $9,897,448 across 23 Biotechnology names. EXEL ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
24,744 | $2,804,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,878 | $1,171,008 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
21,072 | $1,146,527 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
14,648 | $838,158 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,221 | $606,507 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
6,111 | $531,351 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,064 | $497,362 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
11,941 | $398,709 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,146,527 | 21,072 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $905,450 | 21,111 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,354,434 | 30,902 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $849,293 | 20,564 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $456,183 | 10,349 | Shares | Sole | 2025-07-09 | |
| No filing history on record for this holder in this stock. | ||||||